An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

Mise à jour : Il y a 4 ans
Référence : NCT00335374

Femme et Homme

Extrait

This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.003 trial


Critère d'inclusion

  • Early-Stage Parkinson’s Disease


Liens